---
title: "BRAF"
date: 2023-04-19 00:00:00
summary: "# Information about BRAF Gene"
tags: ['BRAF', 'MAPkinase', 'cancer', 'mutation', 'treatment', 'prognosis', 'drugresponse', 'genetics']
---

# Information about BRAF Gene

## Introduction
BRAF gene encodes a serine/threonine protein kinase which regulates the MAP kinase/ERKs signaling pathway. This pathway is involved in cellular processes such as proliferation, differentiation, and apoptosis. Mutations in the BRAF gene have been linked to abnormal cell growth and cancer.

## Function
BRAF protein is a key player in the MAP kinase/ERKs signaling pathway, which regulates cellular processes such as cell division and differentiation. Specifically, BRAF is involved in the activation of the downstream protein MEK, which in turn activates ERKs. Mutations in the BRAF gene can lead to overactivation of this pathway, contributing to the development of cancer.

## External IDs and Genomic Location
- BRAF gene ID: 673
- Genomic location: 7q34
- Aliases: NS7, BRAF1

## External Sites
- HGNC: https://www.genenames.org/data/gene-symbol-report/#!/symbol/678
- NCBI Entrez: https://www.ncbi.nlm.nih.gov/gene/673
- Ensembl: https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000157764
- OMIM: https://www.omim.org/entry/164757?search=BRAF&highlight=braf
- UniProtKB/Swiss-Prot: https://www.uniprot.org/uniprot/P15056

## AA Mutation List
- V600E (dbSNP ID: rs113488022)
- G466V (dbSNP ID: rs113994139)
- D594G (dbSNP ID: rs121913495)
- T599I (dbSNP ID: rs121913493)

## Somatic SNVs/InDels with dbSNP ID
- c.1799T>A (dbSNP ID: rs113488022)
- c.1798_1799delinsAA (dbSNP ID: rs121913493)
- c.1781G>A (dbSNP ID: rs118203998)
- c.1780G>A (dbSNP ID: rs113994139)

## Related Disease
Mutations in the BRAF gene have been linked to several types of cancer, including:
- Melanoma
- Colorectal cancer
- Thyroid cancer

## Treatment and Prognosis
Inhibitors of BRAF and MAP kinase/ERKs signaling pathway can be used to treat BRAF-mutated cancers. The prognosis depends on the type and stage of cancer.

## Drug Response
BRAF inhibitors such as vemurafenib and dabrafenib have been effective in treating BRAF-mutated melanomas. However, drug resistance can develop over time.

## Related Papers
- Subject: BRAF mutation in melanoma
  - Author: Davies H, Bignell GR, Cox C, et al.
  - DOI: 10.1038/nature05610
- Subject: BRAF-targeted therapy in melanoma
  - Author: Sosman JA, Kim KB, Schuchter L, et al.
  - DOI: 10.1056/NEJMoa1002011
- Subject: BRAF inhibitors in colorectal cancer
  - Author: Corcoran RB, Andr√© T, Atreya CE, et al.
  - DOI: 10.1056/NEJMoa1516948

#BRAF #MAPkinase #cancer #mutation #treatment #prognosis #drugresponse #genetics